Literature DB >> 31210663

Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes.

Guopei Luo, Zhiyao Fan, Yitao Gong, Kaizhou Jin, Chao Yang, He Cheng, Dan Huang1, Quanxing Ni, Chen Liu, Xianjun Yu.   

Abstract

OBJECTIVES: Except pancreatic adenocarcinoma, pancreatic cancer has several uncommon histological subtypes, including invasive intraductal papillary mucinous neoplasm (IPMN), pancreatic neuroendocrine tumor (pNET), adenosquamous carcinoma, invasive mucinous cystic neoplasm (MCN), acinar cell carcinoma (ACC), squamous cell carcinoma (SCC), and invasive solid pseudopapillary tumor (SPT). However, features of theses uncommon subtypes are not systematically analyzed.
METHODS: Subjects with different histological subtypes of pancreatic cancers were retrieved from the Surveillance, Epidemiology, and End Results registry. Characteristics and behaviors of uncommon subtypes were compared.
RESULTS: Pancreatic adenocarcinoma (85.8%) represented most primary pancreatic cancers, and other subtypes were rare (14.2%). Features of uncommon subtypes included females with SPT and MCN, located at the pancreatic body/tail of pNET, SPT, and MCN; poor differentiation of adenosquamous carcinoma and SCC; and large size of MCN, SPT, ACC, and SCC. In addition, IPMN, pNET, MCN, ACC, and SPT were indolent. For indolent subtypes, patients with locoregional tumor had prominent prognosis compared with patients with distant disease, especially for invasive IPMN (median survival, localized, 30.0 months; regional, 11.0 months; distant, 4.0 months).
CONCLUSIONS: The study systematically summarizes characteristics and behaviors of primary pancreatic cancer by histological subtypes, which can facilitate the management of pancreatic cancer.

Entities:  

Mesh:

Year:  2019        PMID: 31210663     DOI: 10.1097/MPA.0000000000001338

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  22 in total

Review 1.  Pancreatic cancer: branched-chain amino acids as putative key metabolic regulators?

Authors:  Lenka Rossmeislová; Jan Gojda; Katarína Smolková
Journal:  Cancer Metastasis Rev       Date:  2021-12-28       Impact factor: 9.264

Review 2.  Imaging and Clinicopathological Features of Acinar Cell Carcinoma.

Authors:  Qianqian Qu; Yinghui Xin; Yifan Xu; Yao Yuan; Kai Deng
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

3.  Light at Night and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study.

Authors:  Qian Xiao; Rena R Jones; Peter James; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Res       Date:  2021-01-29       Impact factor: 12.701

4.  Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Huangbao Li; Weiwei Pan; Liu Xu; Dong Yin; Shuqun Cheng; Fengqing Zhao
Journal:  Med Sci Monit       Date:  2021-08-16

5.  Actin gamma 1 is a critical regulator of pancreatic ductal adenocarcinoma.

Authors:  Yichen Tang; Xuehui Peng; Xiaobing Huang; Jing Li
Journal:  Saudi J Gastroenterol       Date:  2022 May-Jun       Impact factor: 3.214

6.  Adenosquamous Carcinoma of the Pancreas.

Authors:  Hélène Del Arco; Camille Chakiba-Brugère; Laura Salabert; Dominique Béchade
Journal:  Clin Med Insights Oncol       Date:  2019-11-05

7.  Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies.

Authors:  Ryan R Kawalerski; Steven D Leach; Luisa F Escobar-Hoyos
Journal:  Oncotarget       Date:  2021-03-16

8.  Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report.

Authors:  Mariacristina Di Marco; Riccardo Carloni; Stefania De Lorenzo; Cristina Mosconi; Andrea Palloni; Elisa Grassi; Daria Maria Filippini; Angela Dalia Ricci; Alessandro Rizzo; Alessandro Di Federico; Donatella Santini; Daniela Turchetti; Claudio Ricci; Carlo Ingaldi; Laura Alberici; Francesco Minni; Rita Golfieri; Giovanni Brandi; Riccardo Casadei
Journal:  World J Gastrointest Oncol       Date:  2020-12-15

9.  Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults.

Authors:  Christiana Kartsonaki; Yuanjie Pang; Iona Millwood; Ling Yang; Yu Guo; Robin Walters; Jun Lv; Michael Hill; Canqing Yu; Yiping Chen; Xiaofang Chen; Eric O'Neill; Junshi Chen; Ruth C Travis; Robert Clarke; Liming Li; Zhengming Chen; Michael V Holmes
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

10.  Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy.

Authors:  Chen Liu; He Cheng; Kaizhou Jin; Zhiyao Fan; Yitao Gong; Yunzhen Qian; Shengming Deng; Qiuyi Huang; Quanxing Ni; Xianjun Yu; Guopei Luo
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.